Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Clinical trial NCT07595003 · RECRUITING

Trial details

NCT number: NCT07595003
Sponsor: Valenta Pharm JSC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Cholecystitis Biliary Dyskinesia

Start date: 2025-12-12
Primary completion: 2027-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.